{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:39:04Z","timestamp":1790314744680,"version":"4.1.0"},"reference-count":18,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0353","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T22:40:10Z","timestamp":1543531210000},"page":"149-155","source":"Crossref","is-referenced-by-count":23,"title":["Clinical outcomes of 20 Japanese patients with insulinoma treated with diazoxide"],"prefix":"10.1507","volume":"66","author":[{"given":"Yoshihiro","family":"Niitsu","sequence":"first","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Izumiyama","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Preemptive Medicine and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Satou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Tama Medical Center, Tokyo 183-8524, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyoshi","family":"Tsujino","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Tama Medical Center, Tokyo 183-8524, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Yokohama City Minato Red Cross Hospital, Kanagawa 231-8682, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Iglesias P, Diez JJ (2014) Management of endocrine disease: a clinical update on tumor-induced hypoglycemia. Eur J Endocrinol 170: R147\u2013R157.","DOI":"10.1530\/EJE-13-1012"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, et al. (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103: 153\u2013171.","DOI":"10.1159\/000443171"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Hansen JB (2006) Towards selective Kir6.2\/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives. Curr Med Chem 13: 361\u2013376.","DOI":"10.2174\/092986706775527947"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Gill GV, Rauf O, MacFarlane IA (1997) Diazoxide treatment for insulinoma: a national UK survey. Postgrad Med J 73: 640\u2013641.","DOI":"10.1136\/pgmj.73.864.640"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Komatsu Y, Nakamura A, Takihata M, Inoue Y, Yahagi S, et al. (2016) Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia. Endocr J 63: 311\u2013314.","DOI":"10.1507\/endocrj.EJ15-0428"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Grant CS (2005) Insulinoma. Best Pract Res Clin Gastroenterol 19: 783\u2013798.","DOI":"10.1016\/j.bpg.2005.05.008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Adachi J, Mimura M, Minami I, Kakihana K, Watanabe T (2014) Thrombocytopenia induced by diazoxide in a patient with an insulinoma. Intern Med 53: 759\u2013762.","DOI":"10.2169\/internalmedicine.53.1094"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Palladino AA, Stanley CA (2011) A specialized team approach to diagnosis and medical <i>versus<\/i> surgical treatment of infants with congenital hyperinsulinism. Semin Pediatr Surg 20: 32\u201337.","DOI":"10.1053\/j.sempedsurg.2010.10.008"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ferrer-Garcia JC, Iranzo Gonzalez-Cruz V, Navas-DeSolis S, Civera-Andres M, Morillas-Arino C, et al. (2013) Management of malignant insulinoma. Clin Transl Oncol 15: 725\u2013731.","DOI":"10.1007\/s12094-012-0996-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Rozance PJ (2014) Update on neonatal hypoglycemia. Curr Opin Endocrinol Diabetes Obes 21: 45\u201350.","DOI":"10.1097\/MED.0000000000000027"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 de Lonlay P, Fournet JC, Touati G, Groos MS, Martin D, et al. (2002) Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr 161: 37\u201348.","DOI":"10.1007\/s004310100847"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Koch-Weser J (1976) Diazoxide. N Engl J Med 294: 1271\u20131273.","DOI":"10.1056\/NEJM197606032942306"},{"key":"13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1542\/peds.40.1.90","volume":"40","author":"JT Combs","year":"1967","unstructured":"13 Combs JT, Grunt JA, Brandt IK (1967) Hematologic reactions to diazoxide. Pediatrics 40: 90\u201392.","journal-title":"PEDIATRICS","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(67)92461-0","volume":"1","author":"J Wales","year":"1967","unstructured":"14 Wales J, Wolff F (1967) Hematological side-effects of diazoxide. Lancet 1: 53\u201354.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Welters A, Lerch C, Kummer S, Marquard J, Salgin B, et al. (2015) Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers. Orphanet J Rare Dis 10: 150.","DOI":"10.1186\/s13023-015-0367-x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 George JN, Aster RH (2009) Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program 2009: 153\u2013158.","DOI":"10.1182\/asheducation-2009.1.153"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Uemura H, Shinohara N, Yuasa T, Tomita Y, Fujimoto H, et al. (2010) A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety. Jpn J Clin Oncol 40: 194\u2013202.","DOI":"10.1093\/jjco\/hyp146"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Service FJ, McMahon MM, O\u2019Brien PC, Ballard DJ (1991) Functioning insulinoma\u2014incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66: 711\u2013719.","DOI":"10.1016\/S0025-6196(12)62083-7"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/2\/66_EJ18-0353\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T05:15:39Z","timestamp":1662527739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/2\/66_EJ18-0353\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0353","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}